Why domperidone comes up in milk-supply conversations

Domperidone blocks dopamine receptors, and one downstream effect of that is a rise in prolactin, the hormone most directly involved in milk production. Because of this, some clinicians outside the United States have prescribed domperidone off-label to parents with a confirmed low milk supply, typically after other approaches such as feeding-frequency changes, lactation support, and other galactagogues have been tried without enough improvement. This is an off-label use, meaning it falls outside the condition domperidone was originally studied and approved for in the countries where it is approved at all.

What the research suggests about effectiveness

Clinical studies on domperidone for low milk supply are relatively small in number and scale compared to studies of its digestive uses, and results vary in how much of a supply increase is observed and how consistent it is across different populations. Some lactation-focused reviews describe a modest benefit for certain parents, while others note that effect sizes are inconsistent and that study quality varies. This is a case where the honest answer is "it may help some people, under supervision, but it is not a guaranteed or uniformly agreed-upon approach," rather than a simple yes-or-no.

The safety warning that matters most here

This is the single most important thing to understand on this page: health authorities, including the FDA, have specifically warned against using domperidone to increase milk supply, separate from any general safety discussion of the drug. The core concern is the same cardiac one described on our Side Effects & Safety page — a risk of QT-interval prolongation and, in rare cases, serious heart rhythm problems — which the FDA considers an unacceptable risk to take on for an indication that was never formally studied and approved for this purpose in the U.S.

Other countries have taken a range of positions. Some allow off-label prescribing for this purpose under a physician's direct supervision, with cardiac history screening beforehand, while still cautioning against unsupervised or unmonitored use. This variation is exactly why "how much domperidone to take for lactation" is not a question this guide will answer with a number: any dosing decision for this purpose needs to come from a physician who has reviewed the individual's cardiac history, current medications, and overall health.

Questions to bring to a doctor or lactation consultant

  • Have other, non-medication approaches to low supply been fully explored first?
  • Do you have any personal or family history of heart rhythm problems or unexplained fainting?
  • What other medications or supplements are you currently taking, and could any interact?
  • What monitoring, if any, would be recommended during use?
  • What is the plan for stopping or tapering, and for how long is use typically considered?

What this page is not

This page does not provide a dose, a duration, or instructions for obtaining domperidone for lactation use, because doing so responsibly requires an individualized medical evaluation that a website cannot replace. If you are exploring this option, the appropriate next step is a conversation with your OB/GYN, primary care physician, or a certified lactation consultant, who can weigh your specific health history against the evidence.

Safety note: the FDA has specifically warned against using domperidone to increase milk supply due to potential cardiac risk. This is not a decision to make without direct medical supervision.

Related reading

For further reading on medication use during lactation, see the NIH LactMed database.